MiniMed Group Inc’s Quiet Period Will Expire Tomorrow (NASDAQ:MMED)

MiniMed Group’s (NASDAQ:MMED) quiet period will end on Wednesday, April 15th. MiniMed Group had issued 28,000,000 shares in its public offering on March 6th. The total size of the offering was $560,000,000 based on an initial share price of $20.00. During MiniMed Group’s quiet period, insiders and underwriters involved in the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Analysts Set New Price Targets

A number of analysts have weighed in on MMED shares. Evercore started coverage on MiniMed Group in a research report on Tuesday, March 31st. They set an “outperform” rating and a $20.00 price objective for the company. Deutsche Bank Aktiengesellschaft started coverage on MiniMed Group in a research report on Tuesday, March 31st. They set a “buy” rating and a $20.00 price objective for the company. Morgan Stanley started coverage on MiniMed Group in a research report on Tuesday, March 31st. They set an “overweight” rating and a $19.00 price objective for the company. Bank of America started coverage on MiniMed Group in a research report on Tuesday, March 31st. They set a “buy” rating and a $27.00 price objective for the company. Finally, Citigroup started coverage on MiniMed Group in a research report on Tuesday, March 31st. They set a “buy” rating and a $23.00 price objective for the company. Eleven investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $22.45.

MiniMed Group Stock Performance

MMED opened at $14.39 on Tuesday. MiniMed Group has a 12 month low of $12.80 and a 12 month high of $20.48.

MiniMed Group Company Profile

We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.